These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25150583)

  • 21. Polymorphisms in the H19 gene and the risk of bladder cancer.
    Verhaegh GW; Verkleij L; Vermeulen SH; den Heijer M; Witjes JA; Kiemeney LA
    Eur Urol; 2008 Nov; 54(5):1118-26. PubMed ID: 18262338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A single-nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances bladder cancer susceptibility.
    Tasci AI; Tugcu V; Ozbek E; Ozbay B; Simsek A; Koksal V
    BJU Int; 2008 Feb; 101(4):503-7. PubMed ID: 17986285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CYP1A2-163C/A (rs762551) polymorphism and bladder cancer risk: a case-control study.
    Song YL; Wang L; Ren JC; Xu ZH
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic variants in the death receptor 4 gene contribute to susceptibility to bladder cancer.
    Wang M; Wang M; Cheng G; Zhang Z; Fu G; Zhang Z
    Mutat Res; 2009 Feb; 661(1-2):85-92. PubMed ID: 19070628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association between -330T/G polymorphism of interleukin 2 gene and bladder cancer.
    Shen Y; Liu Y; Liu S; Zhang A
    DNA Cell Biol; 2012 Jun; 31(6):983-7. PubMed ID: 22242968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer: a meta-analysis.
    Li D; Liu H; Yan L; Tang Y; Ren J; Xu Z
    Urol Int; 2012; 88(1):88-94. PubMed ID: 22156293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relationship between genetic polymorphism of NAT2 and susceptibility to urinary bladder cancer].
    Hao GY; Zhang WD; Chen YH; Zhang DX; Zhang YH
    Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):283-6. PubMed ID: 15312364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study.
    Lin J; Spitz MR; Wang Y; Schabath MB; Gorlov IP; Hernandez LM; Pillow PC; Grossman HB; Wu X
    Carcinogenesis; 2004 Sep; 25(9):1639-47. PubMed ID: 15117811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional POR A503V is associated with the risk of bladder cancer in a Chinese population.
    Xiao X; Ma G; Li S; Wang M; Liu N; Ma L; Zhang Z; Chu H; Zhang Z; Wang SL
    Sci Rep; 2015 Jun; 5():11751. PubMed ID: 26123203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India.
    Srivastava DS; Mandhani A; Mittal RD
    Arch Toxicol; 2008 Sep; 82(9):633-9. PubMed ID: 18200441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions between cigarette smoking and XPC-PAT genetic polymorphism enhance bladder cancer risk.
    Liu Y; Wang H; Lin T; Wei Q; Zhi Y; Yuan F; Song B; Yang J; Chen Z
    Oncol Rep; 2012 Jul; 28(1):337-45. PubMed ID: 22505326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Relationship between genetic polymorphism of promoter region let-7 and genetic susceptibility to hepatocellular carcinoma].
    Huang F; Hu LM; Liu JB; Zhang YX; Hu ZB
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Dec; 45(12):1093-8. PubMed ID: 22336344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of TP53 PRO47SER and ARG72PRO single nucleotide polymorphisms in the susceptibility to bladder cancer.
    Santos LE; Guilhen AC; de Andrade RA; Sumi LG; Ward LS
    Urol Oncol; 2011; 29(3):291-4. PubMed ID: 19523860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of vitamin-D receptor (Fok-I) gene polymorphism with bladder cancer in an Indian population.
    Mittal RD; Manchanda PK; Bhat S; Bid HK
    BJU Int; 2007 Apr; 99(4):933-7. PubMed ID: 17378851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CCR2-64I is a risk factor for development of bladder cancer.
    Narter KF; Agachan B; Sozen S; Cincin ZB; Isbir T
    Genet Mol Res; 2010 Apr; 9(2):685-92. PubMed ID: 20449800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphisms of glutathione S-transferase μ and θ, MDR1 and VEGF genes as risk factors of bladder cancer: a case-control study.
    Henríquez-Hernández LA; Navarro P; Luzardo OP; Alvarez-León EE; Boada LD; Zumbado M; Pestano J; Suárez JR; Chesa N; Almeida M; Valerón PF
    Urol Oncol; 2012 Sep; 30(5):660-5. PubMed ID: 21292509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the T-786C, G894T, and Intron 4 VNTR (4a/b) polymorphisms of the endothelial nitric oxide synthase gene on the risk of prostate cancer.
    Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
    Urol Oncol; 2013 Oct; 31(7):1132-40. PubMed ID: 22317880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Base excision repair pathway genes polymorphism in prostate and bladder cancer risk in North Indian population.
    Mittal RD; Mandal RK; Gangwar R
    Mech Ageing Dev; 2012 Apr; 133(4):127-32. PubMed ID: 22019847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombospondin 1 polymorphism associated with decreased expression and increased risk of pterygium.
    Simon LS; Keshav V; Baharozian C; Masli S; Lee HJ
    Graefes Arch Clin Exp Ophthalmol; 2021 Aug; 259(8):2301-2307. PubMed ID: 33661363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.